ET Healthcare

About:

ET Healthcare develops an automated immunodiagnostics solution.

Website: http://www.ethealthcare.com.cn/

Top Investors: Qiming Venture Partners, Legend Capital, Matrix Partners China, Maison Capital

Description:

ET Healthcare develops an automated immunodiagnostics solution designed to address comprehensive needs, including inflammation, cardiac function, fertility, infectious diseases, and tumors. Pylon, a product from ET Healthcare, is intended to bring immunoassay performance typically associated with central lab analyzers to the near-patient setting. This entails addressing specific near-patient testing requirements such as reduced facility requirements for space, plumbing, and electricity, as well as lower demand for human resources such as trained operators or staff numbers.

Total Funding Amount:

$130M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Shanghai, Shanghai, China

Founded Date:

2008-01-01

Founders:

Bob Zuk, Hong Tan

Number of Employees:

251-500

Last Funding Date:

2021-04-18

IPO Status:

Private

Industries:

© 2025 bioDAO.ai